Psoriatic disease encompasses a spectrum of chronic, immune-mediated conditions, primarily manifesting as psoriasis and psoriatic arthritis. These conditions not only affect the skin and joints but also carry significant systemic implications, including cardiovascular disease, diabetes, and mental health disorders. This evolving understanding highlights the need for comprehensive care and patient advocacy worldwide.
Psoriasis is a chronic autoimmune disease characterized by the rapid turnover of skin cells, which leads to thickened, scaly patches on the skin. These plaques often appear on the scalp, elbows, knees, and lower back but can occur anywhere on the body. Psoriasis is not just a skin disorder but a systemic inflammatory condition that can significantly impact a patient’s quality of life.
The severity of psoriasis varies, ranging from small, localized patches to widespread plaques covering a significant portion of the body. Symptoms include:
Erythrodermic Psoriasis: A severe and rare form causing widespread redness, scaling, and discomfo
In May 2014, the World Health Assembly (WHA) adopted the Psoriasis Resolution (“WHA67.9”), marking a historic milestone in the recognition and management of the disease. This resolution resulted from extensive advocacy by patient organizations, the International Federation of Psoriasis Associations (IFPA) members, and other global stakeholders.
The Psoriasis Resolution redefined how psoriasis is perceived and managed worldwide. Key outcomes included:
This global acknowledgment has fueled advocacy efforts to improve patients’ lives, ensuring that psoriasis is no longer seen as merely a cosmetic condition but a complex disease with systemic implications.
Psoriasis is more than a skin condition. It is part of a broader category known as psoriatic disease, which includes psoriatic arthritis and other comorbid conditions. These systemic manifestations underscore the need for a multidisciplinary approach to care.
PsA is inflammatory arthritis that affects the joints and entheses (where tendons and ligaments attach to bones). Symptoms include joint pain, stiffness, and swelling. If untreated, it can lead to permanent joint damage.
Psoriasis is associated with several comorbid conditions, including:
Despite advances in treatment and advocacy, significant challenges remain:
The 2014 Psoriasis Resolution has empowered patient organizations to advocate for better policies and healthcare services. By fostering collaborations among healthcare providers, policymakers, and patient communities, we can address psoriatic disease holistically. The ultimate goal is not just managing the disease but improving the overall quality of life for millions of affected people.
Psoriasis is more than a skin condition. It is part of a broader category known as psoriatic disease, which includes psoriatic arthritis and other comorbid conditions. These systemic manifestations underscore the need for a multidisciplinary approach to care.
PsA is inflammatory arthritis that affects the joints and entheses (where tendons and ligaments attach to bones). Symptoms include joint pain, stiffness, and swelling. If untreated, it can lead to permanent joint damage.
Psoriasis is associated with several comorbid conditions, including:
Despite advances in treatment and advocacy, significant challenges remain
Many patients, especially in low- and middle-income countries, lack access to proper diagnosis and treatment.
Misconceptions about contagious psoriasis affect patients’ social and professional lives.
There is a need for integrated care that addresses the disease's physical and psychological aspects.
The 2014 Psoriasis Resolution has empowered patient organizations to advocate for better policies and healthcare services. By fostering collaborations among healthcare providers, policymakers, and patient communities, we can address psoriatic disease holistically. The ultimate goal is not just managing the disease but improving the overall quality of life for millions of affected people.